TriangleRadiation Therapy (NCT06129747)
Radiation Therapy trial for Breast Cancer (NCT06129747). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for people over eighteen with selected breast cancers or ductal carcinoma in situ recurring in the same breast, at least three years after whole-breast radiation. Tumors must be under three centimeters and removed with clear margins.
The idea: repeat breast-conserving surgery is followed by fifteen partial-breast radiation treatments over three weeks. The total dose is 40.05 gray; selected higher-risk patients may receive 48 gray. Researchers track severe side effects and local control.
This phase 2 study plans 55 patients. Janice Lyons and Rahul Tendulkar lead at two recruiting Cleveland sites.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.